Aplastic anaemia is a rare but serious blood disorder that affects the body’s ability to produce enough healthy blood cells. It occurs when the bone marrow, normally a busy factory for red cells, white cells, and platelets, begins to slow down or shut down entirely. When this happens, the blood cannot carry oxygen efficiently, fight infections effectively, or clot properly.
Many patients experience symptoms gradually, while others may experience sudden, severe complications. This article explains what aplastic anaemia is, why it develops, and how it impacts the different components of the blood.
Aplastic anaemia occurs when the bone marrow becomes damaged or suppressed, leading to a major drop in blood cell production. Instead of generating millions of cells every day, the marrow becomes empty or is replaced with fat.
Key characteristics include:
Markedly low blood cell counts across all three cell lines.
Higher vulnerability to infections and bleeding.
Increased fatigue due to lack of oxygen-carrying red cells.
Symptoms worsen over time without proper treatment.
Dependency on medical interventions to maintain stable levels.
This condition can affect people of any age, though it is more common in teenagers, young adults, and older individuals.
Bone marrow failure in aplastic anaemia can result from several mechanisms. Many cases involve the immune system mistakenly attacking bone marrow stem cells. Other contributing factors include:
Exposure to toxic chemicals such as benzene.
Certain viral infections disrupt bone marrow function.
Side effects of medications or radiation exposure.
Genetic disorders that weaken marrow activity.
Autoimmune responses that destroy stem cells.
Regardless of the trigger, once the marrow becomes suppressed, the production of essential blood cells decreases sharply.
Because blood cells perform different roles, the symptoms of aplastic anaemia are broad and affect multiple systems in the body.
Common symptoms include:
Extreme tiredness and shortness of breath.
Pale skin and cold extremities due to low red cells.
Frequent or severe infections caused by low white cells.
Easy bruising, prolonged bleeding, or nosebleeds from low platelets.
Rapid heart rate or chest discomfort during exertion.
Symptoms often start subtly but worsen as blood cell counts continue to fall.
The consequences of aplastic anaemia extend to all major components of the blood:
When red blood cells drop, the body struggles to transport oxygen efficiently. This leads to:
Severe fatigue
Dizziness or fainting
Headaches
Difficulty exercising or performing routine tasks
Low white blood cells weaken the immune system, making infections more common and more dangerous. Patients may experience:
Recurrent fevers
Persistent sore throat
Slow recovery from minor illnesses
Platelets are necessary for clotting. Extremely low platelet counts result in:
Easy bleeding
Blood in urine or stools
Spontaneous bruising
Gum or nose bleeding.
Because all three cell types are affected simultaneously, aplastic anaemia is considered a life-threatening condition if left untreated.
While some cases have no identifiable cause, known risk factors include:
Viral illnesses such as hepatitis, Epstein-Barr virus, or HIV.
Autoimmune conditions cause immune-mediated marrow failure.
Being exposed to industrial chemicals or pesticides.
Chemotherapy or radiation is used for cancer treatment.
Inherited conditions like Fanconi anaemia.
Understanding these risks allows patients and clinicians to take preventive measures when possible.
Diagnosis involves a combination of clinical evaluation and laboratory testing.
Standard diagnostic steps include:
Complete blood count (CBC) to check overall cell levels.
Peripheral blood smear to study cell shapes and presence.
A bone marrow biopsy is the most definitive test to evaluate marrow activity.
Liver and kidney function tests to rule out other causes.
Viral testing and immune system assessments.
Accurate diagnosis helps determine the severity and guides treatment decisions.
Aplastic anaemia treatment varies according to severity, age, and underlying cause.
Common management strategies include:
Immunosuppressive therapy to reduce immune attacks on the marrow.
Blood transfusions are used to improve red cell and platelet levels temporarily.
Bone marrow or stem cell transplant is the only potential cure for many patients.
Antibiotics and antivirals to prevent or treat infections.
Platelet-boosting agents, including advanced treatments such as Revolade 50mg, which contains Eltrombopag, are used to stimulate platelet production under medical supervision.
Treatment requires careful monitoring to avoid complications and maintain stable blood levels.
Living with aplastic anaemia involves ongoing care, lifestyle adjustments, and medical follow-up.
Patients often need to:
Avoid crowded places or sick individuals to reduce infection risk.
Monitor for signs of bleeding or new bruising.
Maintain a balanced diet and stay hydrated.
Follow medication schedules strictly.
Attend regular check-ups for repeat blood tests.
Long-term management helps stabilise symptoms and improves overall quality of life.
Aplastic anaemia is a serious disorder that affects the production of all major blood cells, leading to fatigue, bleeding problems, and a high risk of infections. With proper diagnosis, treatment, and ongoing care, patients can achieve better stability and maintain a healthier, more secure life.
